Browse 349 uterine cancer clinical trials enrolling across the United States and Canada. Search by city or state to find one near you.
Endometrial cancer, which starts in the lining of the uterus, is the most common gynecologic cancer in the United States and one of the few cancers whose death rate has been rising. The most common early warning sign is bleeding after menopause, which is why it is often found early and treated with surgery. Research matters most for cancer that returns or has spread, where immunotherapy combined with chemotherapy became a standard first treatment only in the past few years, and trials are testing new targeted drugs matched to the tumor's genetic profile.
Sponsor: University of Miami Sylvester Comprehensive Cancer Center
Sex: Female
Age: 21+
Code: NCT05721976
Recruiting
Pembrolizumab and Lenvatinib in Mismatch Repair Proficient Recurrent Endometrial Cancer After Progression on or Following First-Line Immunotherapy Maintenance
for
Recurrent Endometrial Cancer
Location: Miami FL
Sponsor: University of Miami
Sex: Female
Age: 18+
Code: NCT07594015
Phase 2, Recruiting
A Study to Estimate Early Clinical Efficacy Signals of GLP-1 Agonist Administration in Conjunction With Levonorgestrel Intrauterine Device in Obese Patients With Endometrioid Intraepithelial Neoplasia
for
Endometrioid Endometrial Adenocarcinoma
Location: Gainesville FL
Sponsor: University of Florida
Sex: Female
Age: 18+
Code: NCT07107334
Phase 2, Recruiting
Testing Nivolumab With or Without Ipilimumab in Deficient Mismatch Repair System (dMMR) Recurrent Endometrial Carcinoma